Primary brain tumors and mobile cell phone usage
Subsequent good quality studies have strengthened, not weakened this observation, with one showing an odds ratio for glioma increased to 3.0 (CI 1.7-5.2) in the>25year latency group [4]; the French CERENAT collaborative case-control study demonstrating an odds ratio for glioma of 2.89 (CI 1.41-5....
Gespeichert in:
| Veröffentlicht in: | Cancer epidemiology 2016-10, Vol.44, p.123-124 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 124 |
|---|---|
| container_issue | |
| container_start_page | 123 |
| container_title | Cancer epidemiology |
| container_volume | 44 |
| creator | Wojcik, Damian P., BS, MBChB, DipObs, DCH, FACNEM, FIBCMT, FRNZCGP, Master Forensic Medicine (Monash), FFCFM (RCPA) |
| description | Subsequent good quality studies have strengthened, not weakened this observation, with one showing an odds ratio for glioma increased to 3.0 (CI 1.7-5.2) in the>25year latency group [4]; the French CERENAT collaborative case-control study demonstrating an odds ratio for glioma of 2.89 (CI 1.41-5.93) in the heaviest users (>896h) [5], and a third demonstrating significantly poorer outcome in patients with Astrocytoma grade IV (Glioblastoma Multiforme=GBM), in heavy compared with light cell phone users, when the latency was longer (>20years), and particularly when first cell phone usage was before the age of 20 years [6]. |
| doi_str_mv | 10.1016/j.canep.2016.08.007 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1835382676</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1877782116301217</els_id><sourcerecordid>4213457091</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-b569742762394e59c57c39f25ad943f7a469461f038e3043eaa2ccd0bd7c442b3</originalsourceid><addsrcrecordid>eNqFkVtLxDAQhYMo7rr6CwQp-OJLay5t0j4oyOINFhRU8C2k6VRTe1mTrbD_3tRdV9gXnzKBb87MOYPQMcERwYSfV5FWLcwj6j8RTiOMxQ4ak1SIUKTsdXdTUzJCB85VGHNOSLKPRlQknMc8GyP8aE2j7DLIrTJtsOibzrpAtUXQdLmpIdBQ18H8vWsh6J16g0O0V6rawdH6naCXm-vn6V04e7i9n17NQh3HdBHmCc9ETAWnLIshyXQiNMtKmqgii1kplJ8ec1JilgLDMQOlqNYFzgsxCORsgs5WunPbffbgFrIxbljGe-56J0nKEpZSLrhHT7fQqutt67fzFE2pd8uIp9iK0rZzzkIp5yvrkmA5BCor-ROoHAKVOJU-UN91stbu8waKTc9vgh64WAHgw_gyYKXTBloNhbGgF7LozD8DLrf6dW1ao1X9AUtwf06koxLLp-Gmw0kJZ5hQItg3jLqZ4A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1828227531</pqid></control><display><type>article</type><title>Primary brain tumors and mobile cell phone usage</title><source>Elsevier ScienceDirect Journals</source><creator>Wojcik, Damian P., BS, MBChB, DipObs, DCH, FACNEM, FIBCMT, FRNZCGP, Master Forensic Medicine (Monash), FFCFM (RCPA)</creator><creatorcontrib>Wojcik, Damian P., BS, MBChB, DipObs, DCH, FACNEM, FIBCMT, FRNZCGP, Master Forensic Medicine (Monash), FFCFM (RCPA)</creatorcontrib><description>Subsequent good quality studies have strengthened, not weakened this observation, with one showing an odds ratio for glioma increased to 3.0 (CI 1.7-5.2) in the>25year latency group [4]; the French CERENAT collaborative case-control study demonstrating an odds ratio for glioma of 2.89 (CI 1.41-5.93) in the heaviest users (>896h) [5], and a third demonstrating significantly poorer outcome in patients with Astrocytoma grade IV (Glioblastoma Multiforme=GBM), in heavy compared with light cell phone users, when the latency was longer (>20years), and particularly when first cell phone usage was before the age of 20 years [6].</description><identifier>ISSN: 1877-7821</identifier><identifier>EISSN: 1877-783X</identifier><identifier>DOI: 10.1016/j.canep.2016.08.007</identifier><identifier>PMID: 27566469</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Acoustics ; Brain cancer ; Brain research ; Cancer ; Carcinogens ; Cellular telephones ; Epidemiology ; Hematology, Oncology and Palliative Medicine ; Internal Medicine ; Telephone service ; Tumors</subject><ispartof>Cancer epidemiology, 2016-10, Vol.44, p.123-124</ispartof><rights>Elsevier Ltd</rights><rights>2016 Elsevier Ltd</rights><rights>Copyright Elsevier Limited 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-b569742762394e59c57c39f25ad943f7a469461f038e3043eaa2ccd0bd7c442b3</citedby><cites>FETCH-LOGICAL-c442t-b569742762394e59c57c39f25ad943f7a469461f038e3043eaa2ccd0bd7c442b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1877782116301217$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27566469$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wojcik, Damian P., BS, MBChB, DipObs, DCH, FACNEM, FIBCMT, FRNZCGP, Master Forensic Medicine (Monash), FFCFM (RCPA)</creatorcontrib><title>Primary brain tumors and mobile cell phone usage</title><title>Cancer epidemiology</title><addtitle>Cancer Epidemiol</addtitle><description>Subsequent good quality studies have strengthened, not weakened this observation, with one showing an odds ratio for glioma increased to 3.0 (CI 1.7-5.2) in the>25year latency group [4]; the French CERENAT collaborative case-control study demonstrating an odds ratio for glioma of 2.89 (CI 1.41-5.93) in the heaviest users (>896h) [5], and a third demonstrating significantly poorer outcome in patients with Astrocytoma grade IV (Glioblastoma Multiforme=GBM), in heavy compared with light cell phone users, when the latency was longer (>20years), and particularly when first cell phone usage was before the age of 20 years [6].</description><subject>Acoustics</subject><subject>Brain cancer</subject><subject>Brain research</subject><subject>Cancer</subject><subject>Carcinogens</subject><subject>Cellular telephones</subject><subject>Epidemiology</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Internal Medicine</subject><subject>Telephone service</subject><subject>Tumors</subject><issn>1877-7821</issn><issn>1877-783X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkVtLxDAQhYMo7rr6CwQp-OJLay5t0j4oyOINFhRU8C2k6VRTe1mTrbD_3tRdV9gXnzKBb87MOYPQMcERwYSfV5FWLcwj6j8RTiOMxQ4ak1SIUKTsdXdTUzJCB85VGHNOSLKPRlQknMc8GyP8aE2j7DLIrTJtsOibzrpAtUXQdLmpIdBQ18H8vWsh6J16g0O0V6rawdH6naCXm-vn6V04e7i9n17NQh3HdBHmCc9ETAWnLIshyXQiNMtKmqgii1kplJ8ec1JilgLDMQOlqNYFzgsxCORsgs5WunPbffbgFrIxbljGe-56J0nKEpZSLrhHT7fQqutt67fzFE2pd8uIp9iK0rZzzkIp5yvrkmA5BCor-ROoHAKVOJU-UN91stbu8waKTc9vgh64WAHgw_gyYKXTBloNhbGgF7LozD8DLrf6dW1ao1X9AUtwf06koxLLp-Gmw0kJZ5hQItg3jLqZ4A</recordid><startdate>20161001</startdate><enddate>20161001</enddate><creator>Wojcik, Damian P., BS, MBChB, DipObs, DCH, FACNEM, FIBCMT, FRNZCGP, Master Forensic Medicine (Monash), FFCFM (RCPA)</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20161001</creationdate><title>Primary brain tumors and mobile cell phone usage</title><author>Wojcik, Damian P., BS, MBChB, DipObs, DCH, FACNEM, FIBCMT, FRNZCGP, Master Forensic Medicine (Monash), FFCFM (RCPA)</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-b569742762394e59c57c39f25ad943f7a469461f038e3043eaa2ccd0bd7c442b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Acoustics</topic><topic>Brain cancer</topic><topic>Brain research</topic><topic>Cancer</topic><topic>Carcinogens</topic><topic>Cellular telephones</topic><topic>Epidemiology</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Internal Medicine</topic><topic>Telephone service</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wojcik, Damian P., BS, MBChB, DipObs, DCH, FACNEM, FIBCMT, FRNZCGP, Master Forensic Medicine (Monash), FFCFM (RCPA)</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer epidemiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wojcik, Damian P., BS, MBChB, DipObs, DCH, FACNEM, FIBCMT, FRNZCGP, Master Forensic Medicine (Monash), FFCFM (RCPA)</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Primary brain tumors and mobile cell phone usage</atitle><jtitle>Cancer epidemiology</jtitle><addtitle>Cancer Epidemiol</addtitle><date>2016-10-01</date><risdate>2016</risdate><volume>44</volume><spage>123</spage><epage>124</epage><pages>123-124</pages><issn>1877-7821</issn><eissn>1877-783X</eissn><abstract>Subsequent good quality studies have strengthened, not weakened this observation, with one showing an odds ratio for glioma increased to 3.0 (CI 1.7-5.2) in the>25year latency group [4]; the French CERENAT collaborative case-control study demonstrating an odds ratio for glioma of 2.89 (CI 1.41-5.93) in the heaviest users (>896h) [5], and a third demonstrating significantly poorer outcome in patients with Astrocytoma grade IV (Glioblastoma Multiforme=GBM), in heavy compared with light cell phone users, when the latency was longer (>20years), and particularly when first cell phone usage was before the age of 20 years [6].</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>27566469</pmid><doi>10.1016/j.canep.2016.08.007</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1877-7821 |
| ispartof | Cancer epidemiology, 2016-10, Vol.44, p.123-124 |
| issn | 1877-7821 1877-783X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1835382676 |
| source | Elsevier ScienceDirect Journals |
| subjects | Acoustics Brain cancer Brain research Cancer Carcinogens Cellular telephones Epidemiology Hematology, Oncology and Palliative Medicine Internal Medicine Telephone service Tumors |
| title | Primary brain tumors and mobile cell phone usage |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T05%3A20%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Primary%20brain%20tumors%20and%20mobile%20cell%20phone%20usage&rft.jtitle=Cancer%20epidemiology&rft.au=Wojcik,%20Damian%20P.,%20BS,%20MBChB,%20DipObs,%20DCH,%20FACNEM,%20FIBCMT,%20FRNZCGP,%20Master%20Forensic%20Medicine%20(Monash),%20FFCFM%20(RCPA)&rft.date=2016-10-01&rft.volume=44&rft.spage=123&rft.epage=124&rft.pages=123-124&rft.issn=1877-7821&rft.eissn=1877-783X&rft_id=info:doi/10.1016/j.canep.2016.08.007&rft_dat=%3Cproquest_cross%3E4213457091%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1828227531&rft_id=info:pmid/27566469&rft_els_id=1_s2_0_S1877782116301217&rfr_iscdi=true |